Malaria vaccine (VMP001) - Walter Reed Army Institute of Research

Drug Profile

Malaria vaccine (VMP001) - Walter Reed Army Institute of Research

Alternative Names: AS01B; VMP001; VMP001/AS01B

Latest Information Update: 15 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Walter Reed Army Institute of Research
  • Class Antimalarials; Parasitic vaccines
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Malaria

Most Recent Events

  • 15 Sep 2015 No recent reports on development identified - Phase-I/II for Malaria (Prevention, In volunteers) in USA (IM)
  • 01 Dec 2011 Walter Reed Army Institute of Research completes a phase I/II trial for Malaria prevention in USA (NCT01157897)
  • 08 Jul 2010 Phase-I/II clinical trials in Malaria prevention in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top